Zobrazeno 1 - 10
of 151
pro vyhledávání: '"RK Hills"'
Autor:
J Daniels, J Gray, H Pattison, T Roberts, E Edwards, P Milner, L Spicer, E King, RK Hills, R Gray, L Buckley, L Magill, N Elliman, B Kaambwa, S Bryan, R Howard, P Thompson, KS Khan
Publikováno v:
Health Technology Assessment, Vol 13, Iss 42 (2009)
Objective: To determine the accuracy, acceptability and cost-effectiveness of polymerase chain reaction (PCR) and optical immunoassay (OIA) rapid tests for maternal group B streptococcal (GBS) colonisation at labour. Design: A test accuracy study was
Externí odkaz:
https://doaj.org/article/9d2a1235817a411aa6499ca24feb133d
Autor:
Russell NH; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Thomas A; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Thomas I; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Gilkes A; Cardiff University School of Medicine, Cardiff, United Kingdom., Almuina NM; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Burns S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Marsh L; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Vyas P; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Metzner M; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., McCarthy N; University of Birmingham College of Medicine and Health, Birmingham, United Kingdom., Andrew G; Laboratory of Myeloid Malignancies, National Heart Lung and Blood Institute, Bethesda, MD., Byrne J; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Sellar RS; UCL Cancer Institute and University College London Hospital, London, United Kingdom., Kelly R; St James University Hospital, Leeds, United Kingdom., Cahalin P; Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom., Overgaard UM; University Hospital Rigshospitalet, Copenhagen, Denmark., Mehta P; The University of Bristol and Weston NHS Trust, Bristol, United Kingdom., Dennis M; The Christie NHS Foundation Trust, Manchester, United Kingdom., Knapper S; Cardiff University School of Medicine, Cardiff, United Kingdom., Freeman SD; University of Birmingham College of Medicine and Health, Birmingham, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 18, pp. JCO2400259. Date of Electronic Publication: 2024 Nov 18.
Autor:
Pinter J; University Hospital Würzburg, 97080, Würzburg, Germany. pinter_j@ukw.de., Tunnicliffe DJ; Sydney School of Public Health, The University of Sydney Centre for Kidney Research, The Children's Hospital at Westmead, Camperdown, Australia., Karunikaikumar P; Julius Maximillian University, Würzburg, Germany., Anastasiadis A; University Hospital Würzburg, 97080, Würzburg, Germany., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Publikováno v:
Systematic reviews [Syst Rev] 2024 Nov 14; Vol. 13 (1), pp. 280. Date of Electronic Publication: 2024 Nov 14.
Autor:
Williams CJM; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., Gray R; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.; Deceased., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Shires M; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Zhang L; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Zhao Z; Roche Diagnostics Solutions, Imaging and Algorithms, Digital Pathology, Santa Clara, CA., Gardner T; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Sapanara N; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Xu XM; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Bai I; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Yan D; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Muranyi A; Roche Diagnostics Solutions, Research and Development, Oro Valley, AZ., Dance S; Roche Diagnostics Limited, Medical Affairs, Burgess Hill, West Sussex, United Kingdom., Aghaei F; Roche Diagnostics Solutions, Imaging and Algorithms, Digital Pathology, Santa Clara, CA., Hemmings G; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Hale M; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Kurkure U; Roche Diagnostics Solutions, Imaging and Algorithms, Digital Pathology, Santa Clara, CA., Guetter C; Roche Diagnostics Solutions, Imaging and Algorithms, Digital Pathology, Santa Clara, CA., Richman SD; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Hutchins G; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Seligmann JF; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom., West NP; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom., Singh S; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Shanmugam K; Roche Diagnostics Solutions, Clinical Development and Medical Affairs, Oro Valley, AZ., Quirke P; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 10; Vol. 42 (29), pp. 3430-3442. Date of Electronic Publication: 2024 Jul 31.
Autor:
Halik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Tilgner M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Silva P; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Estrada N; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Altwasser R; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jahn E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany., Hou HA; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Pratcorona M; Hospital de la Santa Creu i Sant Pau. Institut de Recerca Sant Pau. Department of Medicine, Universitat Autonoma of Barcelona, Barcelona, Spain., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Metzeler KH; Department of Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University Hospital Leipzig, Leipzig, Germany., Fenwarth L; Unité Mixte de Recherche (UMR) 9020-UMR1277, Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, University of Lille, Centre National de la Recherche Scientifique (CNRS), INSERM, Centre Hospitalo-Universitaire (CHU) Lille, Institut de Recherche sur le Cancer de Lille (IRCL), Lille, France., Dolnik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Terre C; Laboratoire de Cytogénétique, Service de Biologie, CH de Versailles, Le Chesnay, France., Kopp K; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Blau O; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Szyska M; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Christen F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Krönke J; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Vasseur L; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France., Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Esteve J; Hematology Department, IDIBAPS, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, and Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Duchmann M; Institut de Recherche Saint-Louis (IRSL), Institut National de la Santé et de la Recherche Médicale (INSERM) U944, Centre National de la Recherche Scientifique (CNRS) UMR 7212 GenCellDis, Université Paris Cité, Paris, France., Chou WC; Division of Hematology, Department of Internal Medicine, and Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei City, Taiwan., Linch DC; Department of Haematology, University College London Cancer Institute, London, UK., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gale RE; Department of Haematology, University College London Cancer Institute, London, UK., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany., Yoshida K; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan., Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany. frederik.damm@charite.de.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Aug 19; Vol. 17 (1), pp. 70. Date of Electronic Publication: 2024 Aug 19.
Autor:
Copland M; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK., Ariti C; Centre for Trials Research, Cardiff University, Cardiff, UK.; Oxon Epidemiology, Madrid, Spain., Thomas IF; Centre for Trials Research, Cardiff University, Cardiff, UK., Upton L; Centre for Trials Research, Cardiff University, Cardiff, UK., Sydenham M; Centre for Trials Research, Cardiff University, Cardiff, UK., Mehta P; University Hospitals of Bristol and Weston NHS Trust, Bristol, UK., Islam S; Department of Haematology, Waikato Hospital, Hamilton, New Zealand., Kjeldsen L; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Burnett AK; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Russell N; Guy's and St Thomas' NHS Trust, London, UK., Dennis M; The Christie, Manchester, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 871-876. Date of Electronic Publication: 2023 Nov 28.
Autor:
Georgi JA; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Stasik S; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kramer M; AvenCell Europe GmbH, Dresden, Germany., Meggendorfer M; MLL Münchner Leukämielabor GmbH, Munich, Germany., Röllig C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Haferlach T; MLL Münchner Leukämielabor GmbH, Munich, Germany., Valk P; Erasmus University Medical Center, Rotterdam, Netherlands., Linch D; Department of Haematology, UCL Cancer Institute, London, UK., Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Duployez N; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Taube F; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Middeke JM; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Platzbecker U; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany., Serve H; Medizinische Klinik 2, Universitätsklinikum Frankfurt, Frankfurt am Main, Germany., Baldus CD; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Kiel, Germany., Muller-Tidow C; Klinik für Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Heidelberg, Germany., Haferlach C; MLL Münchner Leukämielabor GmbH, Munich, Germany., Koch S; MLL Münchner Leukämielabor GmbH, Munich, Germany., Berdel WE; Department of Medicine A, University Hospital Münster, Münster, Germany., Woermann BJ; German Society of Hematology and Oncology, Berlin, Germany., Krug U; Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Hiddemann W; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Spiekermann K; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Boertjes EL; Erasmus University Medical Center, Rotterdam, Netherlands., Hills RK; Nuffield Department of Population Health, Oxford University, Oxford, UK., Burnett A; Department of Haematology, Cardiff University, University Hospital of Wales, Cardiff, UK., Ehninger G; AvenCell Europe GmbH, Dresden, Germany., Metzeler K; Klinik und Poliklinik fur Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany., Rothenberg-Thurley M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Dufour A; Department of Medicine III, University Hospital LMU Munich, Munich, Germany., Dombret H; Hôpital Saint-Louis (AP-HP), EA 3518, Université de Paris, Paris, France., Pautas C; Service d'Hématologie et de thérapie cellulaire, Hôpital Henri Mondor, Créteil, France., Preudhomme C; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Fenwarth L; Institut de Recherche contre le Cancer de Lille, Centre Hospitalier Universitaire de Lille, Lille, France., Bornhäuser M; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Nationales Zentrum für Tumorerkrankungen (NCT), Dresden, Germany., Gale R; Department of Haematology, UCL Cancer Institute, London, UK., Thiede C; Medizinische Klinik und Poliklinik 1, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.; AgenDix GmbH, Dresden, Germany. christian.thiede@uniklinikum-dresden.de.
Publikováno v:
Leukemia [Leukemia] 2024 Feb; Vol. 38 (2), pp. 281-290. Date of Electronic Publication: 2024 Jan 16.
Autor:
Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Thomas A; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Thomas I; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Vyas P; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Gilkes A; Cardiff University School of Medicine, Cardiff, United Kingdom., Metzner M; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Jakobsen NA; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Kennedy A; Wellcome, Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Moore R; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Almuina NM; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Burns S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., King S; Centre for Trials Research, Cardiff University, Cardiff, United Kingdom., Andrew G; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, Bethesda, MD., Gallagher KME; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Sellar RS; UCL Cancer Institute and University College London Hospital, London, United Kingdom., Cahalin P; Blackpool Teaching Hospitals National Health Service Foundation Trust, Blackpool, United Kingdom., Weber D; Odense University Hospital, Odense, Denmark., Dennis M; The Christie National Health Service Foundation Trust, Manchester, United Kingdom., Mehta P; The University of Bristol and Weston National Health Service Trust, Bristol, United Kingdom., Knapper S; Cardiff University School of Medicine, Cardiff, United Kingdom., Russell NH; Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
Publikováno v:
Blood [Blood] 2023 Nov 16; Vol. 142 (20), pp. 1697-1707.
Autor:
Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Nov; Vol. 203 (3), pp. 353-354. Date of Electronic Publication: 2023 Aug 23.
Autor:
Hills RK; Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Jul; Vol. 202 (2), pp. 213-214. Date of Electronic Publication: 2023 Apr 03.